Effects of Radiation Exposure on the Cost-Effectiveness of CT Angiography and Perfusion Imaging in Aneurysmal Subarachnoid Hemorrhage

References

1. 1.↵
   2. Molyneux AJ,
   3. Kerr RS,
   4. Birks J, et al

   ; ISAT Collaborators. Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up. Lancet Neurol 2009;8:427–33 doi:10.1016/S1474-4422(09)70080-8 pmid:19329361

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Springer MV,
   3. Schmidt JM,
   4. Wartenberg KE, et al

   . Predictors of global cognitive impairment 1 year after subarachnoid hemorrhage. Neurosurgery 2009;65:1043–50; discussion 1050–51 doi:10.1227/01.NEU.0000359317.15269.20 pmid:19934963

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Chou CH,
   3. Reed SD,
   4. Allsbrook JS, et al

   . Costs of vasospasm in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 2010;67:345–51; discussion 351–52 doi:10.1227/01.NEU.0000371980.08391.71 pmid:20644420

   CrossRefPubMed
4. 4.↵
   2. Rivero-Arias O,
   3. Gray A,
   4. Wolstenholme J

   . Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom. Cost Eff Resour Alloc 2010;8:6 doi:10.1186/1478-7547-8-6 pmid:20423472

   CrossRefPubMed
5. 5.↵
   2. Smith-Bindman R,
   3. Lipson J,
   4. Marcus R, et al

   . Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 2009;169:2078–86 doi:10.1001/archinternmed.2009.427 pmid:20008690

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Amis ES Jr.,
   3. Butler PF

   ; American College of Radiology. ACR white paper on radiation dose in medicine: three years later. J Am Coll Radiol 2010;7:865–70 doi:10.1016/j.jacr.2010.04.006 pmid:21040868

   CrossRefPubMed
7. 7.↵
   2. Wintermark M,
   3. Lev MH

   . FDA investigates the safety of brain perfusion CT. AJNR Am J Neuroradiol 2010;31:2–3 doi:10.3174/ajnr.A1967 pmid:19892810

   FREE Full Text
8. 8.↵
   2. Goehler A,
   3. Gazelle GS

   . Examining the use of comparative and cost-effectiveness analyses in radiology. AJR Am J Roentgenol 2014;203:939–44 doi:10.2214/AJR.14.12887 pmid:25341130

   CrossRefPubMed
9. 9.↵
   2. Sanelli PC,
   3. Pandya A,
   4. Segal AZ, et al

   . Cost-effectiveness of CT angiography and perfusion imaging for delayed cerebral ischemia and vasospasm in aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol 2014;35:1714–20 doi:10.3174/ajnr.A3947 pmid:24812015

   Abstract/FREE Full Text
10. 10.↵
    2. Meyers PM,
    3. Schumacher HC,
    4. Higashida RT, et al

    ; Joint Writing Group of the Technology Assessment Committee, Society of Neurolnterventional Surgery, Society of Interventional Radiology, Joint Section on Cerebrovascular Neurosurgery of the American Association of Neurological Surgeons and Congress of Neurological Surgeons, Section of Stroke and Interventional Neurology of the American Academy of Neurology. Reporting standards for endovascular repair of saccular intracranial cerebral aneurysms. J Neurointerv Surg 2010;2:312–23 doi:10.1136/jnis.2010.002337 pmid:21990640

    Abstract/FREE Full Text
11. 11.↵
    2. Miller JA,
    3. Dacey RG Jr.,
    4. Diringer MN

    . Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage. Stroke 1995;26:2260–66 doi:10.1161/01.STR.26.12.2260 pmid:7491647

    Abstract/FREE Full Text
12. 12.↵
    2. Kranzinger M,
    3. Jones N,
    4. Rittinger O, et al

    . Malignant glioma as a secondary malignant neoplasm after radiation therapy for craniopharyngioma: report of a case and review of reported cases. Onkologie 2001;24:66–72 pmid:11441284

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Yuan MK,
    3. Tsai DC,
    4. Chang SC, et al

    . The risk of cataract associated with repeated head and neck CT studies: a nationwide population-based study. AJR Am J Roentgenol 2013;201:626–30 doi:10.2214/AJR.12.9652 pmid:23971456

    CrossRefPubMed
14. 14.↵
    2. Henk JM,
    3. Whitelocke RA,
    4. Warrington AP, et al

    . Radiation dose to the lens and cataract formation. Int J Radiat Oncol Boil Phys 1993;25:815–20 doi:10.1016/0360-3016(93)90310-R pmid:8478231

    CrossRefPubMed
15. 15.↵
    2. Berrington de Gonzalez A,
    3. Iulian Apostoaei A,
    4. Veiga LH, et al

    . RadRAT: a radiation risk assessment tool for lifetime cancer risk projection. J Radiol Prot 2012;32:205–22 doi:10.1088/0952-4746/32/3/205 pmid:22810503

    CrossRefPubMed
16. 16.↵
    2. Mnyusiwalla A,
    3. Aviv RI,
    4. Symons SP

    . Radiation dose from multidetector row CT imaging for acute stroke. Neuroradiology 2009;51:635–40 doi:10.1007/s00234-009-0543-6 pmid:19506845

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Diekmann S,
    3. Siebert E,
    4. Juran R, et al

    . Dose exposure of patients undergoing comprehensive stroke imaging by multidetector-row CT: comparison of 320-detector row and 64-detector row CT scanners. AJNR Am J Neuroradiol 2010;31:1003–09 doi:10.3174/ajnr.A1971 pmid:20110373

    Abstract/FREE Full Text
18. 18.↵
    2. Post PN,
    3. Stiggelbout AM,
    4. Wakker PP

    . The utility of health states after stroke: a systematic review of the literature. Stroke 2001;32:1425–29 doi:10.1161/01.STR.32.6.1425 pmid:11387509

    Abstract/FREE Full Text
19. 19.↵
    2. de Rooij NK,
    3. Linn FH,
    4. van der Plas JA, et al

    . Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry 2007;78:1365–72 doi:10.1136/jnnp.2007.117655 pmid:17470467

    Abstract/FREE Full Text
20. 20.↵
    2. Kallmes DF,
    3. Kallmes MH

    . Cost-effectiveness of angiography performed during surgery for ruptured intracranial aneurysms. AJNR Am J Neuroradiol 1997;18:1453–62 pmid:9296186

    Abstract
21. 21.↵
    2. McCarter H,
    3. Furlong W,
    4. Whitton AC, et al

    . Health status measurements at diagnosis as predictors of survival among adults with brain tumors. J Clin Oncol 2006;24:3636–43 doi:10.1200/JCO.2006.06.0137 pmid:16877731

    Abstract/FREE Full Text
22. 22.↵
    2. Busbee BG,
    3. Brown MM,
    4. Brown GC, et al

    . Cost-utility analysis of cataract surgery in the second eye. Ophthalmology 2003;110:2310–17 doi:10.1016/S0161-6420(03)00796-6 pmid:14644712

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Weinstein MC,
    3. Siegel JE,
    4. Gold MR, et al

    . Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996;276:1253–58 doi:10.1001/jama.276.15.1253 pmid:8849754

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Martino J,
    3. Gomez E,
    4. Bilbao JL, et al

    . Cost-utility of maximal safe resection of WHO grade II gliomas within eloquent areas. Acta Neurochir (Wien) 2013;155:41–50 doi:10.1007/s00701-012-1541-8 pmid:23132374

    CrossRefPubMed
25. 25.↵
    2. Camejo MD,
    3. Rupani MK,
    4. Rebenitsch RL

    . A comparative analysis of the cost of cataract surgery abroad and in the United States. Indian J Ophthalmol 2014;62:748–49 doi:10.4103/0301-4738.136288 pmid:25005216

    CrossRefPubMed
26. 26.↵
    2. Sanelli PC,
    3. Anumula N,
    4. Johnson CE, et al

    . Evaluating CT perfusion using outcome measures of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol 2013;34:292–98 doi:10.3174/ajnr.A3225 pmid:22859289

    Abstract/FREE Full Text
27. 27.↵
    2. Ivanidze J,
    3. Kallas ON,
    4. Gupta A, et al

    . Application of blood-brain barrier permeability imaging in global cerebral edema. AJNR Am J Neuroradiol 2016;37:1599–603 doi:10.3174/ajnr.A4784 pmid:27127002

    Abstract/FREE Full Text
28. 28.↵
    2. Ivanidze J,
    3. Kesavabhotla K,
    4. Kallas ON, et al

    . Evaluating blood-brain barrier permeability in delayed cerebral infarction after aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol 2015;36:850–54 doi:10.3174/ajnr.A4207 pmid:25572949

    Abstract/FREE Full Text
29. 29.↵
    2. Dankbaar JW,
    3. de Rooij NK,
    4. Velthuis BK, et al

    . Diagnosing delayed cerebral ischemia with different CT modalities in patients with subarachnoid hemorrhage with clinical deterioration. Stroke 2009;40:3493–98 doi:10.1161/STROKEAHA.109.559013 pmid:19762703

    Abstract/FREE Full Text
30. 30.↵
    2. Schmidt JM,
    3. Wartenberg KE,
    4. Fernandez A, et al

    . Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage. J Neurosurg 2008;109:1052–59 doi:10.3171/JNS.2008.109.12.1052 pmid:19035719

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Carrera E,
    3. Schmidt JM,
    4. Oddo M, et al

    . Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage. Neurosurgery 2009;65:316–23; discussion 323–24 doi:10.1227/01.NEU.0000349209.69973.88 pmid:19625911

    CrossRefPubMedWeb of Science